Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400092155Phase 4Recruiting
Phase 4 trial of dexmedetomidine (4 arms), sponsored by Hebei Eye Hospital. Primary endpoints: Peak systolic velocity, End-diastolic velocity and 2 more. Started Nov 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400092155.